乌司他丁对老年重度脓毒症患者肠屏障功能及预后的影响
巨振兴
（陕西省咸阳市中心医院，陕西 咸阳，712000）
浏览次数：86次 下载次数：580次
摘要：
目的 研究乌司他丁对老年重度脓毒症患者肠屏障功能及预后的影响。方法 将我院收治的60例老年重度脓毒症患者 作为研究对象，随机分为对照组和观察组，各30 例。对照组给予常规治疗，观察组在常规治疗基础上加用乌司他丁。比较两组患者的临床效果。结果 治疗第2天及治疗1周时两组患者的血浆IFABP、DAO、D-Lac、血清PCT 水平及治疗1 周时A原 PACHE域评分均明显优于治疗前，且观察组明显优于对照组（P<0.05）。两组患者28 d 内死亡率比较，差异无统计学意义（P>0.05）。结论 乌司他丁能显著改善老年重度脓毒症患者肠道屏障功能，但其对预后生存率改善作用有限。
关键词：乌司他丁；严重脓毒症；肠屏障功能
中图分类号：R459.7文献标志码：A文章编号：2096-1413(2017)35-0042-02
Effects of ulinastatin on intestinal barrier function and prognosis in elderly patients with severe sepsis
JU Zhen-xing
(Xianyang Central Hospital, Xianyang 712000, China)
ABSTRACT: Objective To study the effects of ulinastatin on intestinal barrier function and prognosis in elderly patients with severe sepsis. Methods Sixty elderly patients with severe sepsis were selected and randomly divided into control group and observation group, with 30 cases in each group. The control group was given routine treatment, and the observation group was treated with ulinastatin on the basis of routine treatment. The clinical effects of the two groups were compared. Results The levels of IFABP, DAO, D-Lac, PCT at 2nd day of the treatment and 1 week after treatment and APACHEⅡ scores at 1 week after treatment of the two groups were better than those before treatment, and those of the observation group were better than the control group (P<0.05). There was no significant difference in the mortality rate between the two groups in 28 days (P>0.05). Conclusion Ulinastatin can significantly improve intestinal barrier function in elderly patients with severe sepsis, but the effect on the improvement of survival rate is limited.
KEYWORDS: ulinastatin; severe sepsis; intestinal barrier function
参考文献：
[1] 李香琴,马晓媛,田李星,等.脓毒症诱导的肠损伤及其防治措施的 研究进展[J].重庆医学,2016,45(11):1571-1573.
[2] 雷亿群,张建平,俞春钊,等.乌司他丁对急性胰腺炎患者炎性因子 的影响[J].中国生化药物杂志,2012,33(6):900-901.
[3] 李俊聪,胡超,杨红明,等.乌司他丁对严重烧伤患者免疫功能的影 响[J].中华烧伤杂志,2016,32(6):345-350.
[4] 高戈,冯喆,常志刚,等.2012 国际严重脓毒症及脓毒性休克诊疗指 南[J].中华危重病急救医学,2013,25(8):501-505.
[5] 王正国.当前脓毒症研究的思考[J].解放军医学杂志,2012,37(11):1011-1014.
[6] 柳梅,李艳萍,范学朋,等.动脉血乳酸对指导脓毒症休克患者肠内 营养开始时机的意义[J].广东医学,2014,35(5):707-709.
[7] 朱承睿,丁仁彧,孙旖旎,等.肠脂肪酸结合蛋白与严重脓毒症患者 肠道损伤的相关性研究[J].中华危重病急救医学,2014,26(6):420-424.
[8] 张俊光,黄东华,韩慕谦,等.肺炎合并脓毒症患儿血清PCT 与 CD4﹢CD25﹢调节性T 淋巴细胞水平相关性分析[J].临床合理用药杂 志,2016,9(10):151-152.
[9] 赵军魁,王云辉,程爱国,等.乌司他丁对重度创伤失血性休克大鼠 肠道屏障的影响[J].河北医药,2012,34(15):2260-2262.
[10] 毛刚,吴清安,刘磊,等.乌司他丁的药理作用机制及临床应用进展 [J].山东医药,2015,59(30):94-96.